WO2020228681A1
|
|
Method and medicine for treating amyotrophic lateral sclerosis
|
CN111465408A
|
|
Method and medicament for preventing or treating osteoarthritis
|
CN111344004A
|
|
Method and medicine for regulating GLP-1/GLP-1R
|
CA3047298A1
|
|
Drug for preventing and treating osteoporosis and use thereof
|
CA3047172A1
|
|
Novel method for treating diabetes
|
CA3046669A1
|
|
Method for preventing and treating skin fibrosis
|
EP3556386A1
|
|
Method for preventing and treating drug-induced renal injury
|
CA3008686A1
|
|
Method for preventing and treating diabetic nephropathy
|
EP3395355A1
|
|
Method for preventing and treating cervical erosion
|
EP3395359A1
|
|
Method for preventing or treating acute thrombosis and chronic thrombosis
|
US2018360930A1
|
|
Method for preventing or treating diabetic retinopathy
|
CA3008186A1
|
|
Novel method for preventing and treating angiocardiopathy
|